ResMed Inc. (RSMDF) Operating margin 2017–2026
ResMed Inc. (RSMDF) operating margin by fiscal year — reported operating income divided by reported revenue.
33.4%FY2026 · since FY2017: 20.6% → 33.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 33.4% | +0.6 pp |
| FY2025 | 32.7% | +4.6 pp |
| FY2024 | 28.2% | +1.4 pp |
| FY2023 | 26.8% | -1.2 pp |
| FY2022 | 28.0% | -0.3 pp |
| FY2021 | 28.3% | +0.9 pp |
| FY2020 | 27.4% | +5.2 pp |
| FY2019 | 22.2% | -0.9 pp |
| FY2018 | 23.2% | +2.6 pp |
| FY2017 | 20.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RSMDF financial trends
RSMDF RevenueRSMDF Net incomeRSMDF Net marginRSMDF Gross profitRSMDF Gross marginRSMDF Operating incomeRSMDF Operating cash flowRSMDF Free cash flowRSMDF Capital expendituresRSMDF Return on equityRSMDF Stock buybacksRSMDF Dividends paidRSMDF Total assetsRSMDF Total liabilitiesRSMDF Shareholders’ equityRSMDF overview →